Monday, July 20, 2015

Best Defense Stocks To Invest In 2016

Best Defense Stocks To Invest In 2016: Airbus Group NV (EADSF)

Airbus Group NV, known as European Aeronautic Defence and Space Company EADS NV, is a Netherlands-based company active within the aerospace and defense sector. The Company manufactures aircrafts, helicopters, commercial space launch vehicles, missiles, satellites, defense systems and defense electronics, and offers services related to these activities. The Company oprates four divisions. The Airbus division comprises the Airbus Commercial and Airbus Military segments, which develop, manufacture, market and sell commercial jet aircrafts, military transport aircrafts and special mission aircrafts, among others. The Eurocopter division develops, markets and sells civil and military helicopters. The Astrium division develops, manufactures and sells satellites, orbital infrastructures and launchers, as well as provides space-related services. The Cassidian division develops, manufactures and sells missiles systems, military combat and training aircrafts, among others. Advisors' Opinion:
  • [By Alanna Petroff]

    Airbus, part of the pan-European aerospace conglomerate EADS (EADSF), is hoping that all airlines will adopt the 18-inch standard for long-haul flights.

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-defense-stocks-to-invest-in-2016.html

Tuesday, July 14, 2015

5 Best Forestry Stocks For 2015

Life insurer Prudential Financial, Inc. (PHR) reported stronger than expected third quarter earnings driven by higher fees in the variable annuity business and increased earnings in its International segment. The company also benefitted from a robust equity market and higher interest rates. From Diamond Hill Capital (Trades, Portfolio)'s Fourth Quarter 2013 Commentary.
Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying
Currently 0.00/512345

Rating: 0.0/5 (0 votes)

Subscribe via Email Subscribe RSS

Best Machinery Companies To Watch For 2016: Renishaw PLC (RSW)

Renishaw plc is a metrology company. The Company is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products. The Company operates in two segments: metrology and healthcare products. The Company�� metrology segment product include Machine Tool Probe Systems, Co-ordinate Measuring Machine (CMM) products, large scale metrology, fixtures, materials research, styli for probe systems, performance testing products, gauging and position encoders. Its healthcare products include Dental Scanners, Raman Microscopes, Dental CAD Software, Neurosurgical robot, Structural and Chemical Analyser, In situ monitors and Neurosurgical Implantables. Advisors' Opinion:
  • [By Inyoung Hwang]

    Renishaw Plc (RSW) tumbled 5.7 percent to 1,580 pence, its lowest price since Aug. 7. The maker of precision tools said revenue for the quarter ended in September fell to 79 million pounds from 95.9 million pounds in the year-ago period.

5 Best Forestry Stocks For 2015: Enersis S A(ENI)

Enersis S.A., an electric utility company, engages in the generation, transmission, and distribution of electricity in Chile, Argentina, Brazil, Colombia, and Peru. It owns and operates hydroelectric, thermal, and wind power plants. As of December 31, 2010, it had 14,833 megawatts of installed capacity with 195 power plants; and 13.3 million distribution customers covering approximately 50 million inhabitants. The company was formerly known as Compania Chilena Metropolitana de Distribucion Electrica S.A and changed its name to Enersis S.A. in August 1988. Enersis S.A. was founded in 1889 and is headquartered in Santiago, Chile. Enersis S.A. is a subsidiary of Endesa Latinoamerica S.A.

Advisors' Opinion:
  • [By Sofia Horta e Costa]

    European stocks were little changed at a one-week high as companies from Eni SpA (ENI) to Volkswagen AG posted profit that exceeded estimates, while a gauge of telecommunications companies retreated.

5 Best Forestry Stocks For 2015: CareFusion Corp (CFN)

CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�� Medical Systems segment�� business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�� disposable products and reusable surgical instruments businesses. The Company�� Procedural Solutions segment�� business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Medical Systems Segment

The Company�� develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy inf! ormation and electronic medical records.

The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers��utilization of its medical equipment products. The Company�� project management, field service organization and customer call centers support its customers before, during and after product installation. The Company�� project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company�� field service organization provides on-site expertise to resolve customers��service issues. The Company�� customer call centers provide additional support to its customers.

The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient�� veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.

The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.

Procedural Solutions Segment

The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segm! ent are u! sed in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.

The Company�� Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company�� Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company�� Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.

The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.

Advisors' Opinion:
  • [By ovenerio]

    In the medical supplies division (17%), Covidien competes with Becton Dickinson (BDX), 3M (MMM), Con- Med, CareFusion (CFN) and First Quality.

    Strengths

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CareFusion (NYSE: CFN  ) , whose recent revenue and earnings are plotted below.

5 Best Forestry Stocks For 2015: Big 5 Sporting Goods Corporation(BGFV)

Big 5 Sporting Goods Corporation, together with its subsidiaries, operates as a sporting goods retailer in the western United States. The company offers athletic shoes, apparel, and accessories, as well as a selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, snowboarding, and roller sports. It also provides various private label merchandise, including shoes, apparel, binoculars, camping equipment, fishing supplies, and snow sport equipment. The company sells private label merchandise under its owned labels comprising Court Casuals, Golden Bear, Harsh, Pacifica, Rugged Exposure, and Triple Nickel; and licensed trademarks, including Avet, Body Glove, Fila, GoFit, Hi-Tec, Maui & Sons, Morrow, and Realm and The Realm. As of February 28, 2012, it operated 406 stores in 12 states under the Big 5 Sporting Goods name. The company was founded in 1955 and is headquartered in El Segundo, California.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Big 5 Sporting Goods (Nasdaq: BGFV  ) , whose recent revenue and earnings are plotted below.

  • [By Peter Graham]

    The Q1 2014�earnings report for Dicks Sporting Goods Inc (NYSE: DKS), a competitor of other sporting goods stocks like Big 5 Sporting Goods Corporation (NASDAQ: BGFV) and�Hibbett Sports, Inc (NASDAQ: HIBB), is scheduled for before the market opens on Tuesday, May 20. Aside from the Dicks Sporting Goods's earnings report, it should be said that Big 5 Sporting Goods Corporation reported Q1 2014 earnings on April 29 (earnings were weak and they hinted at continued troubles ahead due the weak sales trends) while Hibbett Sports, Inc will report Q1 2015 earnings before the market opens on Friday, May 23.�However, Dicks Sporting Goods is heading into earnings this week with positive coverage form analysts.

  • [By Lisa Levin]

    Sporting Goods Stores: This industry jumped 1.38% by 10:40 am. The top performer in this industry was Big 5 Sporting Goods (NASDAQ: BGFV), which rose 3.2%. Big 5 Sporting's trailing-twelve-month revenue is $978.32 million.

Thursday, July 9, 2015

JPMorgan, Other Big Banks Juiced by Mid-Year Stress Tests

NEW YORK (TheStreet) -- The nation's largest banks have sailed through yet another set of stress tests mandated by regulators, showing "the industry is well positioned to increase capital distributions" next year, according to Sterne Agee analyst Todd Hagerman.

Hagerman in a note to clients late on Monday wrote that "the bank-conducted stress-testing results, which extend through 2Q15, demonstrated continued improvement in the trajectory of core profitability, improved expected cumulative loss rates, and higher levels of core capital."

Investors may be confused to be reading about stress tests during the summer, since the largest banks have been undergoing the Federal Reserve's stress tests for the past few years in March, after which the group has announced capital deployment plans for the following year. The good news is that the big banks have come out of this round of tests looking considerably stronger than they did before.

Back in March, the Fed first conducted its annual Dodd-Frank Act Stress Tests (DFAST), to gauge the 18 largest US. Bank holding companies' ability to maintain minimum Basel 1 Tier 1 common equity ratios of 5% through a "severely adverse" economic scenario that included a 4% increase in the unemployment rate, which would have been "above any level experienced over the last 70 years." The severely adverse scenario also included an increase of corporate bond spreads to Treasury bonds of 550 basis points, real GDP declining by 5%, a 50% drop in stock prices and a 20% decline in home prices through the end of 2014. The stress tests in March were based on September 2012 financial data, and showed that all 18 holding companies would survive though the end of 2014 with minimum Tier 1 leverage ratios of at least 5%, except for Ally Financial, the former GMAC. One week after the DFAST results were announced, the Fed incorporated banks' capital return plans into another set of stress tests using the same scenario -- the Comprehensive Capital Analysis and Review (CCAR). All the banks passed CCAR, except for Ally Financial and BB&T (BBT) of Winston-Salem, N.C., which had its capital plan rejected on "qualitative" grounds. JPMorgan Chase (JPM) and Goldman Sachs (GS) received "conditional" approval for their capital plans, but were required to submit revised plans to the Federal Reserve.

Despite only receiving conditional approval of its capital plan, JPMorgan during the second quarter was able to boost its quarterly dividend on common shares to 38 cents from 30 cents, while also announcing approval to repurchase up to $6 billion in common shares through the first quarter of 2014. Self-Administered Stress Tests Look Very Good

Starting this year, the holding companies are required to make public disclosures of the results of their own stress tests by Sep. 30, using a new scenario provided by the Federal Reserve, based on March 31 balance sheet and off-balance sheet exposures.

The new "severely adverse" scenario provided by the Federal Reserve includes a 4% decline in GDP over six quarters, with the unemployment rate increasing to 11.7% over eight quarters. The new scenario also includes a 21% drop in home prices and a decline in stock prices of nearly 60%. The scenario also includes plenty of international economic turmoil. Under the new scenario, the banks would make their scheduled dividend payments, while ceasing common-share repurchases and only issuing new shares under existing employee compensation plans. Yes, executive gravy would continue to be ladled out.

JPMorgan Chase (JPM) on Monday said that under its mid-year stress tests, the company would end up with a small pretax net loss of roughly $300 million for nine quarters through June 2015, with a minimum Tier 1 common equity ratio of 8.5%. The minimum Tier 1 common equity ratio under the latest stress test was up considerably from 7.6% in March. Bank of America (BAC) on Monday disclosed that its mid-year stress test results indicate the company would post pretax losses of $26.1 billion over nine quarters thorough June 2015 under the harsh new scenario, and that its minimum "hypothetical stressed" Tier 1 common equity ratio though the cycle would be 8.4%, which is up from the minimum ratio of 7.7% from the second round of Federal Reserve stress tests (CCAR) in March. That's a very comforting increase for the nation's second-largest bank by total assets, which has been making a determined effort led by CEO Brian Moynihan to trim expenses and work through the huge portfolio of nonperforming mortgage loans and investors' loan repurchase demands, springing mainly from the acquisition of Countrywide Financial in 2008. The bank had previously estimated its losses under the Fed's previous severely adverse scenario would total $44 billion.

Wells Fargo (C) fared even better, saying Monday that its mid-year stress tests showed its Tier 1 common equity ratio would decline under the new severely adverse scenario to a minimum of 9.9% through the second quarter of 2015, with cumulative pretax net losses of $3.8 billion. Under the CCAR in March, Wells Fargo's minimum Tier 1 common equity ratio was 8.3%.

Citigroup (C) said that under its mid-year stress tests its minimum Tier 1 common equity ratio through June 2015 would be 9.1%, increasing from the 8.4% minimum projected by the Fed following the CCAR tests in March. Citi also said that under the new severely adverse economic scenario, its cumulative pretax net loss through the second quarter of 2015 would be $21.2 billion.

Goldman Sachs (GS) said its Minimum Tier 1 leverage ratio under the new scenario would be 8.9%, with cumulative pretax net losses of $6.2 billion through the second quarter of 2015. The estimated minimum Tier 1 common ratio was up slightly from the minimum of 8.6% under the CCAR in March.

The Most-Improved Award goes to Morgan Stanley (MS), which on Monday said its minimum Tier 1 common ratio under the Fed's latest severely adverse scenario through the second quarter of 2015 would be 9.5%, which is way up from the minimum of 6.7% under CCAR. The company also said that under the mid-year stress test scenario, it would post a cumulative pretax profit of about $600 million. Atlantic Equities analyst Richard Staite in a note on Tuesday wrote that the latest round of stress tests "should give these banks confidence to apply to return more capital in 2014." Looking ahead, the banks will be facing federal regulators' new leverage ratio requirements, which haven't yet been finalized, and won't be implemented until the beginning of 2015. Another unknown factor is what the Federal Reserve's March 2014 "severely adverse" scenario for its next round of stress tests will look like. But these latest results are a clear indication that the "big six" U.S. banks "get it," as far as managing to regulators every-changing capital-strength expectations are concerned. According to Hagerman, "capital standards lack uniform harmonization and will likely increase over the foreseeable future, [however]... today's relatively punitive capital levels will likely subside over time as the industry continues to build capital and the associated risks and economic landscape continue to change."

Hot Dow Dividend Companies To Buy Right Now

The excellent mid-year stress tests results underscore a possible long-term opportunity for investors. In light of the market hysteria over Federal Reserve monetary policy and the coming change in leadership at the top, along with such strong market gains this year and last, stocks of the largest U.S. banks may be quite volatile through the end of the year. But the group's valuation to forward earnings is still cheap on a historical basis, with valuations at roughly half their levels before the credit crisis hit in 2008: JPMorgan Chase is the cheapest among the big six on a forward P/E basis, with shares closing at $53.14 Monday and trading for 8.7 times the consensus 2014 earnings estimate of $6.09 a share, according to analysts polled by Thomson Reuters. Since the company had already announced that its third-quarter legal expenses would be roughly $1.5 billion, sell-side analysts EPS estimates seem unlikely to be affected by the expected regulatory settlements this week. Citigroup's shares closed at $51.00 Monday and traded for 9.2 times the consensus 2014 EPS estimate of $5.55 Bank of America closed at $14.53 and traded for 10.7 times the consensus 2014 EPS estimate of $1.36 Wells Fargo closed at $42.89 and traded for 10.7 times the consensus 2014 EPS estimate of $4.01 Goldman closed at $167.02 and traded for 10.8 times the consensus 2014 EPS estimate of $15.52 Morgan Stanley is the most expensive of the big six, at least for the time being, with shares closing at $28.73 Monday and trading for 11.1 times the consensus 2014 EPS estimate of $2.60

-- Written by Philip van Doorn in Jupiter, Fla.

>Contact by Email.

Follow @PhilipvanDoorn

Philip W. van Doorn is a member of TheStreet's banking and finance team, commenting on industry and regulatory trends. He previously served as the senior analyst for TheStreet.com Ratings, responsible for assigning financial strength ratings to banks and savings and loan institutions. Mr. van Doorn previously served as a loan operations officer at Riverside National Bank in Fort Pierce, Fla., and as a credit analyst at the Federal Home Loan Bank of New York, where he monitored banks in New York, New Jersey and Puerto Rico. Mr. van Doorn has additional experience in the mutual fund and computer software industries. He holds a bachelor of science in business administration from Long Island University.

Tuesday, July 7, 2015

Art, antiques investing is for the long haul

Most investments these days exist only as the ones and zeroes of computer code.

You can't get a bond or old-fashioned stock certificate in paper form even if you want one. But art and antiques—now there are two tangible, physical investments that also can grace your home. And if you have a good eye and a long enough holding period, you might actually make some real money.

A few lucky, inadvertent investors may discover a rare armoire in a grandparent's attic or buy a painting when they're young—just because they like it, finding out only years later that the artist got hot.

But what about true investing, as opposed to happenstance? Could you go about buying art or antiques the way you would invest in an exchange-traded fund or real-estate investment trust? Is there significant money to be made?

"Both art and antiques are great investments for people who have money they want to put aside long term," said Kevin Yardumian, a collector of 19th century art and partner with accounting and business advisory firm Gumbiner Savett.

These investments are, however, very illiquid, he cautioned. "You are not going to buy, and then sell, next week."

Despite the long holding periods, art investing is not exclusively for the rich, said Michael Moses, a retired New York University business professor and founder of Beautiful Asset Advisors.

"Our research has shown over the years that art is this wonderful asset class, in the sense that there's a painting for every purse," he said.

Moses added that "low-priced art tends to outperform high-priced art."

A person with a $500,000 investment portfolio might consider putting 10% to 20% into illiquid assets, according to Moses. But art and antiques should be only part of that 20%, he noted.

If an investor is going to spend more on the painting hanging over their couch than they did on the couch itself, "then they should do a little research," Moses said.

Moses is co-creator of the Mei Moses family of fine art in! dexes of art values, which are modeled after the well-known Standard & Poor's/Case-Shiller home price indices of home values.

The art indexes track the prices of individual works sold at auction more than once, for a true "apples to apples" comparison over time. The indexes show that art values rise at about the same rate as stocks.

"The returns of our World All Art Index the past 60 years are slightly below the returns of the S&P 500," Moses said.

So, why invest in art or antiques when putting money into an S&P 500 fund is so easy? There are several reasons, according to Moses and Yardumian.

As with stocks, an individual antique or work of art could perform far better than average. And the Mei Moses indexes show that art prices are, to use investing lingo, highly "non-correlated" to stock prices. So, when your stocks are down, your art might be up, helping to reduce volatility in your overall investment portfolio.

Finally, and most importantly, art and antiques investing can be an awful lot of fun. You might not get much day-to-day enjoyment out of your Dow ETF, but a painting on the wall can please every time you look at it. In addition, the hunt for promising works to invest in can be very exciting.

Much of this is true of antiques, as well, but there is no similar index of their values, according to Moses. Because most antiques sales are conducted through private dealers, he explained, it's too hard to find public sources of concentrated data for meaningful price comparisons over time.

As any viewer of TV's "Antiques Roadshow" knows, the value of antiques can rise over time, as specific craftsmen, styles or periods become popular.

But while an antique individual dresser or chest might soar in value, a virtually identical one might not, because someone refinished it or changed the hardware. Because each antique or work of art is unique, prices fluctuate wildly. This creates both opportunities and hazards for investors.

"Art, like real ! estate, i! s a heterogeneous good," Moses said. "Every object is different."

Yardumian concurred.

"You can get two people who really want something and they will pay an astronomical price," he said. "And then you get someone who really needs to unload something and there's only one buyer."

Both experts agreed that investors in antiques or art need to start with an appreciation of the objects, not a desperate need to make money.

People who become investors—actively seeking works for their potential returns—almost always start out as collectors simply buying works they admire.

"I'll give them the pros and cons," said Yardumian, describing his approach with clients interested in art. "I'll talk to them about the nature of investing in art, [which is] significantly different … than investing in real estate, stocks or bonds or mutual funds."

Art and antiques do not provide the steady income one might earn from stock dividends, bond coupons or rent on property, he noted. So money put into art and antiques is truly tied up.

"There also is no intrinsic value to a work of art," he added.

The paint, canvas and frame used, for instance, don't add to a painting's value. And you can't break an artwork or antique into its components for analysis, the way you can look at a public company's factories, fleets, cash flow and patents.

Collecting art or antiques also means shouldering costs for insurance, expert authentication, shipping and storage in proper conditions of heat, humidity and sunlight—expenses you don't incur with stocks and bonds.

And buying and selling artwork or antiques can entail commissions and markups that can range from 10% to 25% of the work's sales price, Yardumian said. All these expenses chew into returns.

Illiquidity makes art and antiques more akin to real estate than securities. It can easily take six months or more to get a fine painting or sculpture on the auction block, according to Moses.

And the pace of price gains is un! predictab! le.

"You have to have the stomach to just leave the money there," Yardumian said, pointing out that investors should not invest in art or antiques with funds needed for college expenses, retirement or any other purpose with a deadline.

"You would not put money into art that you need to maintain your lifestyle," he advised.

So, what's hot today?

With antiques, it's really impossible to generalize because the market is so fragmented. With art, post-World War II contemporary paintings and Chinese works have been doing well for some time, Moses said.

"New money tends to follow new art," Moses added. Chinese art is rising because newly wealthy Chinese collectors are repatriating works collected in the West over the past century.

If you want to invest in art, Yardumian advises first selecting an area to focus on.

"Find something that you're interested in. It doesn't have to be a lifelong passion," he said. Instead of "just buying a bunch of art, somebody might focus on 20th century modern masters," Yardumian said.

"Then, you should really find somebody who's an expert in that area and can put you in touch with people who can source that kind of art," he said.

And don't mortgage the house to pay for this. Until you're an expert yourself, limit the budget to money you can afford to lose.

CNBC is a USA TODAY content partner offering financial news and commentary. Its content is produced independently of USA TODAY.

More: Alternate investing

More: Wide world of investing

More: Alternatives for "average" investors